PT Darya-Varia Laboratoria Tbk

Rp 1,570As of Sun 8 Nov 2026, 12:00 UTC
IDX:DVLAHealthcare
Country Indonesia
PE (Fwd) •••
TSR 10Y CAGR 4.85%
Div yield 6.69%
ROE 9.23%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.06)
PE TTM 12.36
TSR TTM (1.17%)
Mkt cap Rp 1.758T
ROIC 11.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
Rp 1,506
(4.08%)
(69.10%)
Hold 11|11|3|6|9
4Q25
1Q26
2Q26
3Q26
Earnings per shareRp
23.54
23.96
26.08
26.41
32.48%
21.78%
31.16%
20.56%
RevenueRp B
96.07
97.97
96.46
97.51
(1.13%)
1.51%
(1.86%)
(0.31%)
Peers (US$97.13M)
Cap (US$)
PE
86.37M
6.555x
21.57M
18.12x
Capital
TTM
5Y
10Y
Leveragex
0.784
(0.055)
(0.043)
EBIT/Intx
0.294
0.360
0.364
Own earn%
(106.40)
(37.10)
(33.26)
Sh yield%
48.06
5.63
6.94
Owners
Insiders/Inst%
2.67
44.68
Short interest%
3.85
SBC / revenue%
4.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
9–20
$1 testx
0.3
Incr. ROIC%
36